In Singapore, tumours must be on the Ministry of Health’s indication list in order to be treated and insurance-claimable. This regulation takes into account cost-effectiveness, patient’s prognosis, tumour type and location etc. Please refer to MOH website for further information.
Other than conditions listed in the table, tumours like adult low grade glioma, mediastinal thymoma, left breast cancer etc are not specifically listed. However, on a case by case basis, exceptions can be made as stated in the clause.
Treatment should be given with a curative intent.
Patients of all ages | Notes | Number of fractions |
---|---|---|
Musculoskeletal system | ||
– Chordoma | Up to 35 | |
– Chondrosarcoma | Up to 37 | |
– Spinal and para-spinal bone and soft tissue sarcomas | Up to 37 | |
– Retroperitoneal sarcomas | Up to 35 | |
– Sarcomas requiring concurrent chemotherapy | Up to 37 | |
Central and peripheral nervous system | ||
– Ependymoma | Up to 33 | |
– Pituitary adenoma | Up to 30 | |
– Base of skull meningioma | Up to 30 | |
– Acoustic neuroma | 5 or 30# is dependent on size | 5 or 30 |
– Glioma | Up to 30 | |
Head and neck | ||
– Unresectable head and neck cancers | Up to 35 | |
– Cancers of the paranasal sinuses and other accessory sinuses | Up to 35 | |
– Oropharyngeal cancer | Up to 35 | |
– Nasopharyngeal carcinoma | Up to 33 | |
– Mucosal melanoma | Up to 35 | |
– Post-operative with chemotherapy | Up to 33 | |
Gastro-intestinal | ||
– Esophageal | Up to 30 | |
– Unresectable liver cancer | Up to 20 | |
– Unresectable pancreatic cancer | with chemotherapy | Up to 30# |
– Rectal cancer | with chemotherapy, for dose escalation, or for locally recurrence | Up to 30# |
Urological | ||
– Prostate | Up to 20# | |
– Bladder | with chemotherapy | Up to 33# |
Thorax | ||
– Lung | with chemotherapy | Up to 33# |
– Thymic carcinoma | with chemotherapy | Up to 30# |
Patients younger than 25 years old | ||
Central and peripheral nervous system | ||
– Chordoma/ chondrosarcoma base of skull or spine | Up to 40# | |
– Ependymoma | Up to 39# | |
– Craniopharyngioma | Up to 30# | |
– Primitive neuroectodermal tumours | Up to 33# | |
– Glioma | Up to 30# | |
– Neuroblastoma | Up to 20# | |
– Medulloblastoma | Up to 33# | |
Musculoskeletal | ||
– Ewing, rhabdomyosaroma | Up to 30# | |
– Osteosarcoma | Up to 35# | |
– Paraspinal bone and soft tissue sarcoma | Up to 35# |